The Society for Immunotherapy of Cancer's (SITC) Board of Directors have full responsibility for the management, direction and control of the business, policies and affairs of the society, subject only to limitations set forth in the society's Articles of Incorporation and Bylaws.
*As of the 2017 SITC Board of Directors election, terms for incoming board members shifted to having a Jan. 1 start date of the proceeding new year. An asterisk is denoted below for each of the new board members who began their term on Jan. 1.
President Yale School of Medicine
Vice PresidentUniversity of Texas MD Anderson Cancer Center
Secretary/TreasurerCity of Hope
Immediate Past PresidentParker Institute for Cancer Immunotherapy
Harvard Medical School
Istituto Nazionale Tumori-Fondazione 'G. Pascale'
IGM Biosciences, Inc.
Columbia University Medical Center
UPMC Hillman Cancer Center
Bill & Melinda Gates Medical Research Institute
Massachusetts General Hospital
University of Wisconsin Carbone Cancer Center
University of LausanneEditor-in-ChiefJournal for ImmunoTherapy of Cancer
National Cancer Institute (NCI)NCI Liaison
US Food and Drug Administration, OHOPFDA Liaison
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org